Table 1.
Demographic characteristics of participants
| Variables | All Patients (N = 41) | Control (N = 10) | Obese (N = 11) | Obese + NAFLD (N = 20) | P-value | Difference** |
|---|---|---|---|---|---|---|
| Age(Years, Median, Range) | 14 (10–18) | 13 (10–17) | 12 (10–17) | 15 (10–18) | 0.270a | |
| Gender (N, %) | 0.299b | |||||
| Male | 22 (53.7%) | 5 (12.2%) | 4 (9.8%) | 13 (31.7%) | ||
| Female | 19 (46.3%) | 5 (12.2%) | 7 (17.1%) | 7 (17.1%) | ||
| Height (cm, Median, IQR) | 161 (152–166) | 157 (150–161) | 162 (150–166) | 166 (154–174) | 0.136a | |
| Weight (kg, Median, IQR) | 76 (60–98) | 58 (45–66) | 76 (74–79) | 94 (75–114) | < 0.001* | f = 1 < 2.3 ** |
| BMI (kg/m2, Median, IQR) | 29.7 (25.4–34) | 23.1 (19.87–24.87) | 29.6 (27.8–33.8) | 33.2 (30.9-38.81) | < 0.001* | f = 1 < 2.3 ** |
| BMI SDS (Median, IQR) | 2.30 (2-2.75) | 0.88 (0.68–1.3) | 2.5 (2.15–2.75) | 2.64 (2.15–3.25) | < 0.001* | f = 1 < 2.3 ** |
| WC (cm, Median, IQR) | 100 (91–113) | 66 (50-75.5) | 100 (99–113) | 108 (100-117.5) | < 0.001* | f = 1 < 2.3 ** |
| Tanner Stage (N, %) | 0.871c | |||||
| Stage 2 | 1 (2.4%) | 1 (2.4%) | 0 (0%) | 0 (0%) | ||
| Stage 3 | 8 (19.5%) | 2 (4.9%) | 2 (4.9%) | 4 (9.8%) | ||
| Stage 4 | 11 (26.8%) | 3 (7.3%) | 3 (7.3%) | 5 (12.2%) | ||
| Stage 5 | 21 (51.2%) | 4 (9.8%) | 6 (14.6%) | 11 (26.8%) | ||
| Blood pressure SDS (Median, IQR) | ||||||
| Systolic | 0.8 (0.4–1.4) | 0.4 (0.2–0.6) | 1.1 (0.6–1.6) | 0.9 (0.2–1.6) | 0.049 a | f = 1 < 2.3 ** |
| Diastolic | 1 (0.5–1.5) | 0.3 (0.2–0.7) | 1.23 (0.7–1.8) | 1 (0.4–1.6) | 0.037 a | f = 1 < 2.3 ** |
a: Kruskal Wallis Test, b: Pearson Chi-Square Test; c: Fisher’s Exact Test **: Scheffe test
BMI: Body Mass Index, Cm: Centimeter, IQR: Interquartile Range, Kg: Kilogram, NAFLD: Non-Alcoholic Fatty Liver Disease, SDS: Standard Deviation Score, WC: Waist Circumference
All percentages were calculated based on the total patient population (N = 41)
All p-values less than 0.05 was bold